2021 US Pharma
Financial Strength Rankings using Artificial Intelligence
Top rated | 100 of 402 |
Best rating | 371 % |
Worst rating | -2,690 % |
New companies | 85 |
Negative Economic Capital Ratio | 111 of 402 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 100 of 402 |
Best rating | 371 % |
Worst rating | -2,690 % |
New companies | 85 |
Negative Economic Capital Ratio | 111 of 402 |
GeoVax Labs Inc. climbed 287 positions from 343 to 56 due to its excellent Assets, Current.CNBX Pharmaceuticals Inc. lost 392 positions from 4 to 396 due to its bad Assets, Current.ALX ONCOLOGY HOLDINGS INC entered the 2021 ranking at rank 7, making it the best newcomer.
Revenues | 351 B |
Assets | 1.03 K |
Expenses | 340 B |
Stockholders Equity | 532 B |
Unprofitable Companies | 357 of 402 |
Rank | Company | Seal | Rating Value | Trend |
---|
Rank | Company | Seal | Rating Value | Trend |
---|
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai